Pregled prema Autor
Lavin, Philip T
Prikaz rezultata 1 do 3 od 3
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
| 2022 | Early response to leukocyte interleukin Injection (LI) immunotherapy extends overall survival (OS) in locally advanced primary squamous cell carcinoma of the head & neck (SCCHN): The IT-MATTERS study | Lavin, Philip T; Talor, Eyal; Markovic, D; Cipriano, J | Konferencijski rad | |
| 2022 | Histopathology (HP) biomarkers confirm leukocyte interleukin injection (LI) treatment (Tx) outcome in naive locally advanced primary head & neck squamous cell carcinoma (SCCHN) the IT-MATTERS study | Timar, J; Talor, Eyal; Lavin, Philip T; Ladanyi, A; Kenessey, I; Kiss, A; Markovic, D; Cipriano, J | Konferencijski rad | |
| 2022 | Novel algorithm for assigning risk/disease-directed treatment (DDT) choice in locally advanced primary squamous cell carcinoma head and neck (SCCHN): Using pretreatment data only. | Talor, Eyal; Lavin, Philip T; Markovic, Dusan | Konferencijski rad | |